Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950124-05-001574
Filing Date
2005-03-16
Accepted
2005-03-16 15:11:52
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v06091e10vk.htm 10-K 995052
2 EXHIBIT 10.17 v06091exv10w17.txt EX-10.17 238944
3 EXHIBIT 10.18 v06091exv10w18.txt EX-10.18 4549
4 EXHIBIT 10.19 v06091exv10w19.txt EX-10.19 4279
5 EXHIBIT 10.47 v06091exv10w47.txt EX-10.47 10407
6 EXHIBIT 10.76 v06091exv10w76.txt EX-10.76 845
7 EXHIBIT 21.1 v06091exv21w1.txt EX-21.1 165
8 EXHIBIT 23.1 v06091exv23w1.txt EX-23.1 970
9 EXHIBIT 31.1 v06091exv31w1.txt EX-31.1 3645
10 EXHIBIT 31.2 v06091exv31w2.txt EX-31.2 3716
11 EXHIBIT 32.1 v06091exv32w1.txt EX-32.1 2069
  Complete submission text file 0000950124-05-001574.txt   1267376
Mailing Address 1900 9TH AVENUE SUITE 1100 SEATTLE WA 98101
Business Address 1900 9TH AVENUE SUITE 1100 SEATTLE WA 98101 2063663700
CORIXA CORP (Filer) CIK: 0001042561 (see all company filings)

EIN.: 911654387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22891 | Film No.: 05685105
SIC: 2836 Biological Products, (No Diagnostic Substances)